SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-100409
Filing Date
2016-05-10
Accepted
2016-05-10 16:02:22
Documents
62
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v437910_10q.htm 10-Q 281748
2 EXHIBIT 31.1 v437910_ex31-1.htm EX-31.1 8263
3 EXHIBIT 31.2 v437910_ex31-2.htm EX-31.2 8297
4 EXHIBIT 32.1 v437910_ex32-1.htm EX-32.1 5933
  Complete submission text file 0001144204-16-100409.txt   3367408

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cpxx-20160331.xml EX-101.INS 747748
6 XBRL TAXONOMY EXTENSION SCHEMA cpxx-20160331.xsd EX-101.SCH 38651
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cpxx-20160331_cal.xml EX-101.CAL 38391
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cpxx-20160331_def.xml EX-101.DEF 200755
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cpxx-20160331_lab.xml EX-101.LAB 276981
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cpxx-20160331_pre.xml EX-101.PRE 242722
Mailing Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540 (609) 243-0123
Celator Pharmaceuticals Inc (Filer) CIK: 0001327467 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36179 | Film No.: 161635664
SIC: 2834 Pharmaceutical Preparations